These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33090696)

  • 21. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.
    Del Fresno C; García-Arriaza J; Martínez-Cano S; Heras-Murillo I; Jarit-Cabanillas A; Amores-Iniesta J; Brandi P; Dunphy G; Suay-Corredera C; Pricolo MR; Vicente N; López-Perrote A; Cabezudo S; González-Corpas A; Llorca O; Alegre-Cebollada J; Garaigorta U; Gastaminza P; Esteban M; Sancho D
    Front Immunol; 2021; 12():748103. PubMed ID: 34867974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6.
    Takashita E; Yamayoshi S; Halfmann P; Wilson N; Ries H; Richardson A; Bobholz M; Vuyk W; Maddox R; Baker DA; Friedrich TC; O'Connor DH; Uraki R; Ito M; Sakai-Tagawa Y; Adachi E; Saito M; Koga M; Tsutsumi T; Iwatsuki-Horimoto K; Kiso M; Yotsuyanagi H; Watanabe S; Hasegawa H; Imai M; Kawaoka Y
    N Engl J Med; 2022 Dec; 387(22):2094-2097. PubMed ID: 36383452
    [No Abstract]   [Full Text] [Related]  

  • 23. Endemic SARS-CoV-2 will maintain post-pandemic immunity.
    Veldhoen M; Simas JP
    Nat Rev Immunol; 2021 Mar; 21(3):131-132. PubMed ID: 33402727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of anti-SARS-COV-2 serum IgA titration in patients with COVID-19.
    Lippi G; Mattiuzzi C
    J Med Virol; 2021 Mar; 93(3):1210-1211. PubMed ID: 32966614
    [No Abstract]   [Full Text] [Related]  

  • 25. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
    Vojdani A; Vojdani E; Kharrazian D
    Front Immunol; 2020; 11():617089. PubMed ID: 33584709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals.
    Stelitano D; Weisberg SP; Goldklang MP; Zhu Y; Bovier FT; Kalantarov GF; Greco G; Decimo D; Franci G; Cennamo M; Portella G; Galdiero M; Mathieu C; Horvat B; Trakht IN; Moscona A; Whitt MA; Porotto M
    mSphere; 2021 Aug; 6(4):e0057121. PubMed ID: 34319126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
    Andreano E; Piccini G; Licastro D; Casalino L; Johnson NV; Paciello I; Dal Monego S; Pantano E; Manganaro N; Manenti A; Manna R; Casa E; Hyseni I; Benincasa L; Montomoli E; Amaro RE; McLellan JS; Rappuoli R
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34417349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol 25-hydroxylase expression following immune activation in response to SARS-CoV-2 infection.
    Davidson J; Rotondo D
    Curr Opin Lipidol; 2021 Aug; 32(4):266-267. PubMed ID: 34227577
    [No Abstract]   [Full Text] [Related]  

  • 29. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.
    Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals.
    Markmann AJ; Giallourou N; Bhowmik DR; Hou YJ; Lerner A; Martinez DR; Premkumar L; Root H; van Duin D; Napravnik S; Graham SD; Guerra Q; Raut R; Petropoulos CJ; Wrin T; Cornaby C; Schmitz J; Kuruc J; Weiss S; Park Y; Baric R; de Silva AM; Margolis DM; Bartelt LA
    mSphere; 2021 Aug; 6(4):e0027521. PubMed ID: 34431693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA.
    Zeng W; Ma H; Ding C; Yang Y; Sun Y; Huang X; He W; Xiang Y; Gao Y; Jin T
    Signal Transduct Target Ther; 2021 Jan; 6(1):35. PubMed ID: 33514692
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination of antibody tests against SARS-CoV-2 for health care workers after vaccination.
    Kittanakom S; Richardson DC; Uddayasankar U; Knauer M; Borgia SM; Kavsak PA
    Clin Biochem; 2022 Mar; 101():54-55. PubMed ID: 34843731
    [No Abstract]   [Full Text] [Related]  

  • 34. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
    Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France.
    Zedan HT; Nasrallah GK
    EBioMedicine; 2021 Sep; 71():103580. PubMed ID: 34525435
    [No Abstract]   [Full Text] [Related]  

  • 36. B careful: Humoral responses and COVID-19 severity.
    Fanous H; Guerrero-Pena A; Pillai A
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33277373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha variant SARS-CoV-2 infection: How it all starts.
    Domingo P; de Benito N
    EBioMedicine; 2021 Dec; 74():103703. PubMed ID: 34800902
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission.
    Horiuchi S; Oishi K; Carrau L; Frere J; Møller R; Panis M; tenOever BR
    Sci Immunol; 2021 Dec; 6(66):eabm3131. PubMed ID: 34699266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    Murphy WJ; Longo DL
    N Engl J Med; 2022 Jan; 386(4):394-396. PubMed ID: 34818473
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
    Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
    Front Immunol; 2021; 12():797919. PubMed ID: 34975908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.